Reflecting on Blue Cross Laboratories’ remarkable journey since its inception in 1981, I am filled with immense pride for our achievements and great optimism for an even brighter future.
We use cookies to optimize our website and our service. Cookie Policy
Fenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study